Gastroesophageal Reflux Disease (GERD) is a life-affecting condition that affects as many as 20% of the population. Given the prevalence of GERD, the quest for suitable treatment methods has been a relentless one— but often to little effect.
Dr. Starpoli's Blog
Incisionless Anti-reflux Therapy: a chance to stop your reflux drugs.
Anthony A. Starpoli, MD | www.starpoli.com
Obesity, Reflux, fundoplication, atypical reflux, heartburn, EsophyX, incisionless surgery, GERD Awareness Week
Americans who suffer from either being obese or have gastrointestinal issues can now undergo an incisionless surgical procedure that will control or eradicate their medical challenges with limited pain and reduced surgical recovery time.
Anthony A. Starpoli, MD | www.starpoli.com
EsophyX TIF Procedure is Superior to Maximum Dose PPI Therapy
As reported by Medscape, according to research presented at the Digestive Disease Week meeting, “patients with gastroesophageal reflux disease (GERD) might benefit more from transoral incisionless fundoplication (TIF) than from continued treatment with proton-pump inhibitors (PPIs).” The study’s lead author Karim Trad, MD, said, “In this study, transoral incisionless fundoplication was superior to maximal-dose PPIs in eliminating daily troublesome typical and atypical symptoms in selected patients.” Dr. Trad added that the findings “establish for the first time that, for some patients, the procedure is better than maximal-dose PPI therapy for controlling a range of GERD symptoms.”
Anthony A. Starpoli, MD | www.starpoli.com
hiatal hernia, fundoplication, LINX, GERD, atypical reflux, EsophyX, incisionless surgery, esophageal cancer
Anthony A. Starpoli, MD | www.starpoli.com
Obesity, GERD, atypical reflux, nonacid reflux, heartburn, EsophyX, incisionless surgery, Barrett's Esophagus